Correction: Cancer Mortality in People Treated with Antidepressants before Cancer Diagnosis: a Population Based Cohort Study.

[This corrects the article DOI: 10.1371/journal.pone.0138134.].

In Table 2, the numbers of Population, Person years (PYs), No. of deaths, and Mortality/ 100 PYs are listed incorrectly for current user and former user. Please see the corrected Table 2.

Table 2

Mortality rate ratio (MRR) of cancer mortality after cancer diagnosis for current antidepressant (AD) user and former AD user at time of cancer diagnosis.

AD treatment before diagnosis	Population	Person years (PYs)	No. of deaths	Mortality/ 100 PYs	Crude MRR	Adjusted c MRR (95%CI)	Adjusted d MRR (95%CI)
1-year mortality
No e	168,551	130,809	43,631	33.4	Ref	Ref	Ref
Current user a	21,851	14,503	8,744	60.3	1.75	1.31 (1.28; 1.34)	1.32 (1.29; 1.35)
Former user b	11,260	8,374	3,396	40.6	1.21	1.05 (1.01; 1.08)	1.07 (1.03; 1.11)
Conditional 5-year mortality if patients survived the first year after cancer diagnosis
No e	105,458	236,283	23,799	10.1	Ref	Ref	Ref
Current user a	10,767	22,131	3,172	14.3	1.40	1.19 (1.15; 1.24)	1.22 (1.17; 1.26)
Former user b	6,610	14,646	1,621	11.1	1.10	1.02 (0.97; 1.08)	1.05 (1.00; 1.11)

a Current AD users refers to cancer patients who redeemed an AD prescription within 4 months before the cancer diagnosis.

b Former AD users refers to cancer patients who redeemed the last AD prescription more than 4 months before the cancer diagnosis.

c Adjusted for sex, age at time of diagnosis (5-year interval), Charlson comorbidity index (0, 1–2, 3+), marital status (married or cohabiting, living alone), education (low, medium, high), and calendar year (2003–2004, 2005–2007, 2008–2010).

d Adjusted for cancer stage at time of diagnosis (local, regional, distant, and unknown) besides the factors included in the analysis c.

e The reference refers to cancer patients who had no AD prescription in the 3 years before cancer diagnosis.